The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessing a prognostic model for predicting VTE occurrence in cancer patients.
Deesha Sarma
No relevant relationships to disclose
So Yeon Kim
No relevant relationships to disclose
David H. Henry
Consultant or Advisory Role - Amgen (U)
Honoraria - AMAG Pharmaceuticals; Amgen
Research Funding - Amgen